Oestradiol Levels in Varicose Vein Blood of Patients with and without Pelvic Vein Incompetence (PVI): Diagnostic Implications  by Asciutto, G. et al.
Eur J Vasc Endovasc Surg (2010) 40, 117e121Oestradiol Levels in Varicose Vein Blood of Patients
with and without Pelvic Vein Incompetence (PVI):
Diagnostic ImplicationsG. Asciutto*, A. Mumme, K.C. Asciutto, B. GeierDepartment of Vascular Surgery, St. Josef Hospital, Bochum, Germany
Submitted 14 June 2009; accepted 10 January 2010
Available online 3 March 2010KEYWORDS
Pelvic vein
incompetence;
Oestradiol levels;
Limb varicosity;
Phlebography* Corresponding author at: Kassenbe
E-mail address: hasci@tin.it (G. As
1078-5884/$36 ª 2010 European Socie
doi:10.1016/j.ejvs.2010.01.023Abstract Purpose: To assess the difference in the oestradiol levels of blood taken from vari-
cose veins in patients with and without pelvic vein incompetence (PVI).
Materials and methods: Women of child-bearing age with symptomatic primary or recurrent
varicose veins of the great saphenous vein (GSV) were included in a prospective study. Patients
underwent duplex ultrasonography and pelvic vein phlebography. They were divided into
a group with PVI (PVI group) and a control group with GSV reflux alone (VV group). Blood
samples were collected from the GSV at the sapheno-femoral junction or lower in the thigh
as well as from the arm. Oestradiol levels were determined by electroluminescence.
Results: Between January and December 2007, 40 women were studied, of which 19 showed
phlebographic evidence of PVI (PVI group), while 21 were included in the VV group. Phlebog-
raphy revealed an incompetent ovarian vein in 14 (74%) patients of the PVI group, dilated
uterine and ovarian plexuses in 12 (63%) and an incompetent internal iliac vein in six cases
(32%). In the PVI group, the median oestradiol level in GSV samples was 121 pg ml1 (range:
12e4300), while in the VV group the median level was 75 pgml1 (range: 9e1177). In the upper
limb, the PVI group patients had a median level of 78 pg ml1 (range: 15e121) and the VV group
patients 68 pg ml1 (range: 13e568). The ratio of lower limb/upper extremity was significantly
higher (p< 0.002) in patients of PVI group (median: 1.9; range: 0.7e33) than in those of the VV
group (median: 1.1; range: 0.8e13). A threshold ratio of 1.4 showed the highest combined
sensitivity and specificity in differentiating patients with PVI from those without.
Conclusions: In patients with varicose veins arising from the GSV, oestradiol levels were signif-
icantly higher in the lower limb than in the upper extremity in the subgroup with associated
PVI. It may be possible to use this observation as a diagnostic test in patients with suspected
PVI. This deserves further study.
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118 G. Asciutto et al.The term pelvic vein incompetence (PVI) describes patho-
logical reflux in pelvic veins. It is often associated with
pelvic pain, dyspareunia and pelvic heaviness and might
also play a role in the development of varicose veins.1,2
Invasive and non-invasive diagnostic methods have been
used to detect pelvic reflux. The detection of reflux at the
sapheno-femoral junction (SFJ) originating in the pelvis on
ultrasonography (US) might lead to the suspicion of PVI.3
However, only diagnostic methods requiring the use of
contrast media guarantee reliable detection of pelvic reflux
pathways.4e6 Female sex hormones are mostly produced in
the ovary. Incompetence of pelvic veins could allow reflux
of hormone-rich blood to the SFJ and reach the great
saphenous vein (GSV).
Oswald et al.7 have already measured the hormone
content of varicose veins to assess the role of ovarian vein
incompetence as a source of varicose veins. Building on this
experience, we assumed that if high sex hormone levels
could be detected in the lower limb in patients with phle-
bographic signs of PVI, this could help to select patients
who should undergo contrast media examinations, reducing
diagnostic costs and increasing patient acceptance.
We therefore conducted a prospective study analysing
oestradiol blood levels in the lower and upper limbs in
female patients with primary or recurrent GSV varicose
veins and phlebographic evidence of PVI. We compared
these findings to a control group of patients with isolated
GSV varices.Materials and methods
Female patients of child-bearing age with symptomatic
primary or recurrent GSV varicose veins were recruited
between January and December 2007 at our vascular
centre. The study protocol was approved by our local ethics
committee. Patients were divided into two subgroups: a PVI
and a VV group, depending on the presence of PVI on
phlebography. Not all patients underwent phlebography,
which was only undertaken in those where clinical or
duplex ultrasound scanning suggested that this might be
present. The decision to perform phlebography of the
pelvic veins was based on clinical signs typical of PVI:
a history of vulval varicosities during pregnancy, an
increase in venous congestion symptoms related to the
menstrual period, dyspareunia, lower abdominal pain of
unknown origin as well as a history of repeated surgery for
recurrent varicose veins at the SFJ. PVI was also suspected
if varicose veins were found at atypical sites (buttock,
perineal or vulval region). Duplex ultrasound examinations
were performed in all patients and if reflux was detected in
the groin originating from cranial (epigastric) and/or
medial (pubic and pudendal) veins, PVI was also suspected
and pelvic venography was performed regardless of the
above-mentioned symptoms. All patients gave written
informed consent for their inclusion in this study.
Exclusion criteria included age under 18 years; known
vascular malformation in the abdomen or lower limb;
pregnancy; thrombophlebitis of the GSV; a history of deep
vein thrombosis (DVT) in the lower limb; and previous
allergic reactions to radiological contrast medium. Patients
who met the inclusion criteria underwent a meticulousclinical examination. Previous surgery due to lower limb
varicosity, pregnancies as well as clinical extension of
varicosities (based on ClinicaleEtiologyeAnatomyePatho-
physiology (CEAP) classification8) were recorded.
Phlebography was performed using an imaging technique
based on the descriptions of Ahlberg.9 The examination
proceeded in a standardised fashion with visualisation of
the ovarian veins (OVs) and the common iliac veins (CIVs) in
an antero-posterior projection and of the internal iliac
veins (IIVs) in an oblique projection (30 left or right
anterior oblique).
The presence and the extent of any reflux were docu-
mented and the names of the pelvic veins affected by
reflux were recorded. PVI was considered to be present if
one of the following criteria was fulfilled:
- pelvic reflux toward the ipsi- or contralateral proximal
thigh;
- visualisation of a dilated OV throughout its entire
course;
- retrograde filling of the main stem of the IIV and at
least one tributary (gluteal, ischiadic or obturator
veins); or
- retrograde filling of contrast medium across the
midline.
Based on our previous experience,10 an OV was consid-
ered to be dilated if its diameter was at least 1.5 times that
of the contralateral vessel. If the vein was dilated without
reflux, it was not considered incompetent. In selected
cases, the main ovarian trunk and/or the IIV were embol-
ised with the use of standard spring coils (Gianturco spring
embolisation coils; Cook). Complications were of investi-
gation and treatments were recorded.
Blood samples were collected after venous duplex
ultrasound imaging and diagnosis of GSV incompetence
leading to varicose veins. The GSV was marked with the
help of US at the groin or the proximal part of the medial
thigh. Blood samples were collected as near to the SFJ as
possible using a 23-gauge needle with the patients in
upright position and performing a Valsalva manoeuvre. In
the upper limb, blood was taken from an ante-cubital vein.
The levels of the active form 17-beta-oestradiol were
determined by sandwich electrochemiluminescent immu-
noassay (ECLIA) using the Elecsys 2010 system (Roche,
Mannheim, Germany e coefficient of variation 2e8%). The
time of blood sampling with reference to the menstrual
cycle, hormone replacement therapy or oral contraception
was considered irrelevant due to the intention to compare
oestradiol levels in the upper and lower limbs and not to
analyse absolute values.Statistical analysis
To compare the study and the control groups, we used the
ManneWhitney U-test for ordinal data (assuming non-
normal distribution of data in view of the wide scatter of
results) and Fisher’s exact test categorical data. Descrip-
tors for ordinal data in this study are the median, inter-
quartile range and range of data. Regarding the comparison
of oestradiol levels, in patients with bilateral varicose
Table 1 Demographic data.
PVI group VV group p-Value
Age mean (range) 42 (29e55) 36 (18e52) 0.043 (þ)
Primary varicosity 9 (47%) 4 (19%) 0.091 ()
Recurrence 10 (53) 17 (81%)
CEAP
Class C1 7 (37%) 3 (14%) 0.15 ()
Class C2 12 (63%) 18 (86%)
(þ) ManneWhitney-U-test, () Fisher’s exact test.
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considered for analysis. The maximum difference between
lower limb measurements accepted as reliable was 5%. A
difference of less than 20% between varicose vein blood and
upper limb blood oestradiol levels was considered non-
significant.
In order to define the most predictive lower limb/upper
extremity ratio for the diagnosis of PVI, we calculated
specificity and sensitivity for a range of values of this ration
and plotted a receiver operating characteristic (ROC)
curve.
Results
Between January and December 2007, 40 female patients
were included in this study, of which 19 (48%) patients had
clinical signs and symptoms as well as US findings of PVI and
were included in PVI group, while 21 (52%) patients were
assigned to the VV group. Demographic data are shown in
Table 1. Amongst all patients, there were 13 cases of vari-
cose vein recurrence after previous stripping of the GSV and
in 27 cases of primary varicose veins (see Table 1: demo-
graphic data). The mean number of pregnancies was 2.5 per
patient (range: 0e5). Thirty (75%) patients presented with
CEAP clinical class C2 and 10 (25%) with class C1. There was
no case of oedema of the legs or venous ulceration. Varicose
veins in the thigh and the calf were themain clinical findings.
In the PVI group, 10 patients (53%) had varicose tributaries
originating in the gluteal or groin region and connecting to
varicose veins on the thigh or on the calf.
The standardised phlebography protocol was completed
at the time of hospitalisation in all 19 patients in the PVI
group and confirmed PVI in all cases. There were no adverse
events due to the contrast agent nor was there any case of
bleeding or pelvic vein thrombosis. An incompetent OV was
recognised in 14 (74%) patients of the PVI group, dilated
plexuses in 12 (63%) and an incompetent IIV in six cases
(32%). Endovascular treatment with coil obliteration of the
incompetent veins was performed in 10 cases.Table 2 Oestradiol levels (pg ml1). In patient with bilateral va
considered for comparison. See text for explanation. All data are
PVI grou
Lower limb 121 (12e
Upper extremity 68 (13e
Lower limb/upper extremity ratio 1.1 (0.7
Modified lower limb/upper extremity ratio 1.1 (0.7
(þ) ManneWhitney-U-test.The oestradiol measurements are summarised in Table
2, including the lower limb/upper limb ratios. These data
have been plotted in Fig. 1a and b, confirming that the
lower limb/upper limb ratios are higher in the PVI group. In
order to define the most predictive ratio for diagnosis of
PVI, we plotted the ROC curve (Fig. 2). A threshold ratio of
1.4 showed the highest combined sensitivity and specificity
in differentiating patients with PVI from those without.
Discussion
In 1947, Taylor11 used the term ‘venous congestion
syndrome of the pelvis’ to describe a combination of
symptoms consisting of pelvic varicosities, dysmenorrhoea,
post-coital pain and pelvic pain. This classical tetrad of
symptoms is associated with a typical pattern of varicosi-
ties.1,2 In some cases, incompetent pelvic veins may carry
reflux to the venous system of the lower limb, resulting in
primary varicosities and/or in recurrence after surgical
treatment of varicose veins.2,12 Symptoms often worsen
during menstruation,13 the higher prevalence in multipa-
rous women3 as well as the positive therapeutic effects of
hormonal replacement on symptoms14e16 suggest that sex
hormones might play a crucial role in the pathophysiology
of this peculiar clinical entity.
High oestradiol levels can result from an excessive
medical treatment,17 at the beginning of the menopause18
and rarely due to oestradiol-producing tumours.19 By
contrast, lower oestradiol levels can be caused by an
endocrine disease.20 In addition, hormonal regulation is
influenced by psychiatric diseases, chronic stress, extreme
sport or anorexia.21e23 Oestradiol is transported through
the ovarian veins to the left renal vein as well as to the
inferior vena cava. After liver inactivation, it is eliminated
through the kidneys. In patients with incompetent pelvic or
ovarian veins, the oestradiol-rich blood may flow to the
lower limb veins through multiple connections between the
pelvic and the lower limb venous systems.
In our study population, hormone levelswere higher in the
lower limb than in the upper limb only in patients where PVI
was associated with varicose veins. The patients with PVI
were slightly older than the VV group patients. These data
confirm the observations reported by Oswald et al.,7 who
assessed hormone levels of varicose veins to detect the
incompetence of theOVas a source of varices. These authors
measured the concentration of hormones such as oestrogen,
corticoids and oestradiol in varicose vein blood of 10 patients
with pre-menstrual pain and 10 without. In this group of
patients, there was no significant difference between the
hormone concentration levels in any of the samples in the
group without pain. In the symptomatic group, there was noricosities, the higher oestradiol level in the lower limbs was
median (range).
p VV group p-Value (þ)
1177) 75 (9e4300) N.S.
568) 68 (15e121) N.S.
e33) 1.9 (0.8e13) 0.002
e1.8) 1.9 (0.8e4.7) 0.001
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Figure 1 Oestradiol levels in the study groups. Depicted is
the ratio lower limb/upper extremity. Fig. 1a includes all
patients, while in Fig. 1b patients with the highest levels of
both groups were excluded (see text for explanation). Box and
whisker plots show median (central line), upper and lower
quartiles (box) and range excluding outliers (whiskers).
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Figure 2 ROC curve. Sensitivity and specificity of ratios are
reported. The distance of the curve from the middle values is
correlated to the predictive value of the ratio as tool to
differentiate patients with PVI from patients without PVI. A
threshold ratio of 1.4 showed the highest combined sensitivity
and specificity in differentiating patients with PVI from those
without.
120 G. Asciutto et al.difference between the oestrogen and corticoid blood
concentration. However, in the symptomatic group, the
concentration level of oestradiol in the sample from painful
varicose veins was two to nine times higher compared with
samples from the non-affected leg and brachial vein. Oswald
speculated that the higher concentration of oestradiol was
due to an incompetent ovarian vein, which follows a route
through the pelvis to the varicose veins and which may
explain the high oestrogen content. The severity of PVI was
not be classified inour study sowewereunable to analyse the
correlation between the severity of PVI andoestradiol levels.
We cannot speculate as to whether higher oestradiol levels
may be helpful in detection of PVI without phlebography.
We observed a wide range of oestradiol levels but it is
likely that this may have arisen in part because of the
different menstrual phase in which blood samples were
collected. Failing to record this aspect should be consid-
ered a drawback of this study. Patients were not asked
about medical intake of hormones and/or oral contracep-
tives, which would also influence absolute hormones levels.
Unrecognised endocrine diseases may also have played
a role. We aimed to minimise these differences by basing
our conclusions on hormone ratios rather than absolute
hormone levels. Other limitations of our study includeomission of transvaginal ultrasound imaging. Due to a lack
of experience with transvaginal US of the OV, we decided
not to rely on this diagnostic tool. Some authors have
reported that combined trans-abdominal and transvaginal
US is potentially useful for non-invasive screening to
determine which patients with chronic pelvic pain may
benefit from selective ovarian venography.24 We avoided
undertaking phlebography in patients without signs and
symptoms of PVI so we cannot be sure that all patients in
the VV group were free of pelvic vein incompetence. The
consequences of exposing women of child-bearing age to
radiation and the already-reported high sensitivity and
specificity of US3 in detecting PVI were the main reasons for
avoiding the use of phlebography in asymptomatic patients.
It is also unclear whether there is any value in treating
asymptomatic pelvic vein reflux. Finally, our study involved
relatively few patients and a much larger cohort would
have been required to provide more exact data in view of
the variability of oestradiol levels.
Conclusions
These preliminary data indicate that blood samples taken
from the GSV in the lower limb could help to identify those
patients with clinical signs and symptoms of PVI who should
undergo phlebography. If our findings can be confirmed in
larger cohorts of patients, it may be possible to minimise
the costs of diagnosis for patients with PVI, avoiding
exposure to radiation and contrast media.
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